标题：赵瀛兰
个人简历
赵瀛兰，药学博士,副教授，博士生导师。1998 年毕业于华西医科大学临床医学专业，获医学学士学位。 2000-2004 年在日本名古屋大学从事肿瘤药理学，药代动力学及抗肿瘤多药耐药的研究， 2003 年 9 月获药学博士学位。 2004-2006 年在日本爱知医科大学作为博士后继续从事上述研究。 2006 年 4 月起作为国家“ 985 ”工程引进人才在四川大学生物治疗国家重点实验室，主要从事针对特定靶点的小分子抗肿瘤药物开发研究，在新药研发，肿瘤药理及药代动力学研究方面有丰富的理论及实践经验。 作为课题负责人主持了国家高科技发展计划（ 863 计划），国家重大新药创制临床前新药研究，国家自然科学基金课题及教育部留学回国人员科研启动基金等多项课题。 目前已在国际杂志 Mol Psychiatry(IF12) ， J Neurosci (IF8) ， Antimicrob Agents Chemother ， Life Sci ， Eur J Pharmacol., 等共发表论文近 30 余篇
研究方向
1. 针对特定靶点的小分子新药研发及作用机理研究 ：主要针对恶性肿瘤及神经系统疾病包括急性脑损伤等进行针对特定靶点新药研发应用基础研究，研究内容包括高通量抗肿瘤药物筛选，药效，药代动力学及安全性评价，基于代谢组学及蛋白组学等药物作用机理及安全性研究。
2. 抗肿瘤多药耐药及药代动力学研究： 研究范围包括药物转运载体包括肿瘤多药耐药相关药物载体的调控机理研究，不同疾病状态下药物转运载体的调控和药代动力学特点研究。
代表性论著
· Huang Y , Gao H , Gou M , Ye H , Liu Y , Gao Y , Peng F , Qian Z , Cen X , Zhao Y *. Acute toxicity and genotoxicity studies on poly(varepsilon-caprolactone)-poly(ethylene glycol)-poly(varepsilon-caprolactone) nanomaterials. Mutat Res. 20 10 Jan 7.
· Qian Bu, Guangyan Yan, Pengchi Deng, Feng Peng, Hongjun Lin, YouzhiXu, Zhixing Cao, Tian Zhou, Aiqin Xue, Yanli Wang, Xiaobo Cen and Ying-Lan Zhao * . NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration. Nanotechnology. 2010, 21, 125105.
· Zheng-Guang Li, Ying-Lan Zhao, Xiaohua Wu, Hao-Yu Ye, Aihua Peng, Zhi-Xing Cao, Yong-Qiu Mao, Yu-Zhu Zheng, Pei-Du Jiang, Xia Zhao, Li-Juan Chen and Yu-Quan Wei. Barbigerone, a Natural Isoflavone, Induces Apoptosis in Murine Lung-Cancer Cells via the Mitochondrial Apoptotic Pathway. Cellular Physiology and Biochemistry. 2009;24:95-104.
· Yuzhu Zheng, Ying-Lan Zhao * , Xiaoqiang Deng, Shengyong Yang, Yongqiu Mao, Zhengguang Li, Peidu Jiang, Xia Zhao, and Yuquan Wei. Chloroquine Inhibits Colon Cancer Cell Growth In Vitro and Tumor Growth In Vivo via Induction of Apoptosis. Cancer Investigation. 2009 .27,286-292.
· Pei-du Jiang, Ying-Lan Zhao * , Wei Shi, Xiao-qiang Deng, Gang Xie, Yong-qiu Mao, Zheng-guang Li, Yu-zhu Zheng, Sheng-yong Yang and Yu-quan Wei. Cell Growth Inhibition, G2/M Cell Cycle Arrest, and Apoptosis Induced by Chloroquine in Human Breast Cancer Cell Line Bcap-37. Cellular Physiology and Biochemistry. 2008, 22,431-440.
· Ying-Lan Zhao , Qian Bu, Yan Zhou, Lei Lv, Guangyan Yan, Li Wang, Xiaobo Cen. Mechanism study of Aconitum -induced neurotoxicity in PC12 cells: Involvement of dopamine release and oxidative damage. Neurotoxicology . Accepted.
· Cen X, Nitta A, Ibi D, Zhao Y , Niwa M, Taguchi K, Hamada M, Ito Y, Ito Y, Wang L, Nabeshima T. Identification of Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization. Mol Psychiatry . 2008 Jan 15; [Epub ahead of print]
· Cen X , Nitta A , Ohya S , Zhao Y , Ozawa N , Mouri A , Ibi D , Wang L , Suzuki M , Saito K , Ito Y , Kawagoe T , Noda Y , Ito Y , Furukawa S , Nabeshima T . An analog of a dipeptide-like structure of FK506 increases glial cell line-derived neurotrophic factor expression through cAMP response element-binding protein activated by heat shock protein 90/Akt signaling pathway. J Neurosci. 2006 Mar 22;26(12):3335-44.
· Xiao-Qiang Deng, Hui-Yuan Wang, Ying-Lan Zhao , Ming-Li Xiang, Pei-Du Jiang, Zhi-Xing Cao, Yu-Zhu Zheng, Shi-Dong Luo, Luo-Ting Yu, Yu-Quan Wei and Sheng-Yong Yang. Pharmacophore Modelling and Virtual Screening for Identification of New Aurora-A Kinase Inhibitors. Chem Biol Drug Des . 2008; 71: 533?C539. （ Contributed equally to first author ）
· Wang HY, Cao ZX, Li LL, Jiang PD, Zhao YL , Luo SD, Yang L, Wei YQ, Yang SY. Pharmacophore modeling and virtual screening for designing potential PLK1 inhibitors. Bioorg Med Chem Lett. 2008 Sep 15; 18 ( 18 ): 4972-7 .
· Yamaguchi S, Zhao YL , Nadai M, Yoshizumi H, Cen X, Torita S, Takagi K, Takagi K, Hasegawa T. Involvement of the drug transporters p glycoprotein and multidrug resistance-associated protein Mrp 2 in telithromycin transport. Antimicrob Agents Chemother. 2006 Jan;50(1):80-7. （ Contributed equally to first author ）[1]